Drug Type Small molecule drug |
Synonyms KPAX 002, KPAX002 |
Target |
Mechanism adrenergic receptor modulators(Adrenergic receptors modulators), Central nervous system stimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Fatigue Syndrome, Chronic | Phase 2 | US | 25 Sep 2020 | |
Cognition Disorders | Phase 2 | US | 17 Sep 2020 | |
Persian Gulf Syndrome | Phase 2 | US | 01 Jan 2015 |